文献速递肝病消化道肿瘤与早癌

乙肝病毒表面基因前S2突变体作为肝癌根治性肝切除术后复发的高危血清标志物

Hepatitis B virus surface gene pre-S2 mutant as a high-risk serum marker for hepatoma recurrence after curative hepatic resection.
PubMed 文献 · Hepatology · 2018-05-21

本研究分析乙肝病毒大表面蛋白前S2区突变作为肝细胞癌根治性肝切除术后复发标志物的价值。免疫组化(n=12)和蛋白印迹(n=22)显示大表面蛋白在肿瘤区未见显著降低,提示其在癌变中维持表达。175例乙肝相关肝癌根治性肝切除患者队列分析显示,血清前S2突变体水平和美国癌症联合委员会分期是复发的两个主要独立高危因素,预测模型在主队列和验证队列的曲线下面积分别为0.741和0.704。

要点

  • 大表面蛋白在乙肝相关肝癌肿瘤区未见显著降低,提示其在肿瘤进展中起独特作用。
  • 血清前S2突变体水平独立于肿瘤分期,是肝癌根治性肝切除术后复发的重要高危标志物。
  • 预测模型在主队列和验证队列的曲线下面积分别为0.741和0.704。

核心结论

  • 与主要表面抗原不同,大表面蛋白主要表达于乙肝相关肝癌的肿瘤区域,提示其在肿瘤进展中起独特作用。
  • 血清前S2突变体相对水平独立于肿瘤分期,是肝癌根治性肝切除术后复发的重要高危标志物。

研究设计与样本

  • 免疫组化分析12例、蛋白印迹分析22例,观察肿瘤区大表面蛋白表达。
  • 分析175例接受根治性肝切除的乙肝相关肝癌患者队列,用前S基因芯片检测前S基因突变。
  • 采用多因素回归分析和Cox比例风险分析建立预测模型,并在独立肝癌队列中验证。

主要发现

  • 免疫组化和蛋白印迹显示,以主要表面抗原为主的乙肝表面蛋白在肿瘤中大幅减少,而大表面蛋白在肿瘤区未见显著降低。
  • 多因素回归分析显示,血清前S2突变体水平和美国癌症联合委员会分期是复发的两个主要独立高危因素。
  • Cox比例风险分析建立的预测模型可指示术后无复发生存率,并在独立肝癌队列中验证。
  • 受试者工作特征曲线分析显示,模型在主队列和验证队列的曲线下面积分别为0.741和0.704。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic hepatitis B virus (HBV) infection is the major cause of hepatocellular carcinoma (HCC). The pre-S2 mutant large HBV surface antigen (LHBS) is highly associated with HCC. This study analyzed the expression of the large form of surface protein in tumors and evaluated the LHBS with mutations within the pre-S2 region as a high-risk recurrence marker in HCC patients after curative hepatic resection. By analyses using immunohistochemical staining (n = 12) and western blotting (n = 22), the HBV surface protein, which is mainly comprised of the major form of HBV surface antigen, was greatly diminished in the tumors. However, LHBS was not significantly decreased in tumorous regions, suggesting that LHBS maintains its expression in cancer development. A cohort of 175 patients with HBV-related HCC who underwent curative hepatic resection was analyzed for pre-S gene mutations using Pre-S Gene Chip. Results of the multivariate regression analysis showed that the serum pre-S2 mutant level and the American Joint Committee on Cancer stage were the two main independent high-risk factors for recurrence. A Cox proportional hazards analysis also revealed a prediction model, which indicated the recurrence-free survival rate along with the time after surgery; this was developed and further validated in an independent HCC cohort. Receiver operating characteristic curve analysis revealed that the model showed close sensitivities in the main and validation cohorts (area under the curve values, 0.741 and 0.704, respectively). Conclusion: Unlike the major HBV surface antigen, LHBS is mostly expressed in the tumorous regions of HBV-induced HCC, indicating that it plays a unique role in tumor progression; the relative level of pre-S2 mutant in serum is, independently of tumor stage, an important high-risk marker for HCC recurrence after primary hepatic resection. (Hepatology 2018).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Yen CJ, Ai YL, Tsai HW, et al. Hepatitis B virus surface gene pre-S2 mutant as a high-risk serum marker for hepatoma recurrence after curative hepatic resection. Hepatology. 2018. PMID: 29350774. doi:10.1002/hep.29790

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。